Frederic Godderis
Direttore operativo presso Tranquis Therapeutics, Inc.
Profilo
Frederic Godderis currently works at Tranquis Therapeutics, Inc., as Chief Operating Officer from 2021.
Mr. Godderis received his graduate degree from Katholieke Universiteit Leuven.
Posizioni attive di Frederic Godderis
| Società | Posizione | Inizio |
|---|---|---|
Tranquis Therapeutics, Inc.
 Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Direttore operativo | 26/05/2021 |
Formazione di Frederic Godderis
| Katholieke Universiteit Leuven | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Tranquis Therapeutics, Inc.
Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Health Technology |
- Borsa valori
- Insiders
- Frederic Godderis
